Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

about

A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.

P2860

Q48147173-07F0EB12-782C-4E57-939C-F95F1DDA8720

P2860

Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

Item

http://www.wikidata.org/entity/Q36452240

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@ast

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@en

type

Item

label

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@ast

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@en

prefLabel

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@ast

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@en

P1476

Delayed Efficacy After Treatme ...... ated Lymphoid Tissue Lymphoma.

@en

P2093

Ingrid Simonitsch-Klupp

http://www.w3.org/2001/XMLSchema#string

Markus Raderer

http://www.w3.org/2001/XMLSchema#string

Marlene Troch

http://www.w3.org/2001/XMLSchema#string

Werner Dolak

http://www.w3.org/2001/XMLSchema#string

P2860

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.

Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.

Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.

Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.

Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice.

P304

72-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2015-0176

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marius E. Mayerhoefer

Barbara Kiesewetter

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26621040

http://www.w3.org/2001/XMLSchema#string

P921

thalidomide

P932

4709204

http://www.w3.org/2001/XMLSchema#string

Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

about

P2860

P2860

Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932